The West Australian: ‘Botanix ships first batch of sweat-stopper gel’

/in , , /by

Botanix’s significant progress towards commercialisation has been spotlighted in The West Australian’s Business section, in an article about the shipment of the Company’s ‘first batch of sweat-stopper gel’ to US patients by Cheyanne Enciso.

Read article

First Sofdra™ prescriptions as commercialization ramps up

/in , , , /by

First prescriptions for Sofdra™ (sofpironium) topical gel, 12.45% have shipped to patients after having successfully been diagnosed via telemedicine and cleared insurance approvals. Following sales force deployment, a wider digital program will begin in Q2 2025.

View release.